TY - JOUR
T1 - Chemotherapeutic neuropathy
AU - Windebank, Anthony J.
PY - 1999
Y1 - 1999
N2 - Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.
AB - Peripheral neurotoxicity is a dose-limiting side-effect for a number of effective chemotherapeutic agents, including platinum compounds, taxanes, and vinca alkaloids. New experimental chemotherapy drugs that cause neuropathy include suramin and Dolostatin-10. A better understanding of cellular mechanisms will lead to novel treatment strategies that will protect neurons without decreasing therapeutic efficacy.
UR - http://www.scopus.com/inward/record.url?scp=0033397107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033397107&partnerID=8YFLogxK
U2 - 10.1097/00019052-199910000-00010
DO - 10.1097/00019052-199910000-00010
M3 - Review article
C2 - 10590893
AN - SCOPUS:0033397107
SN - 1350-7540
VL - 12
SP - 565
EP - 571
JO - Current opinion in neurology
JF - Current opinion in neurology
IS - 5
ER -